Professor Kenneth Baillie co-leads the Molecular Mechanisms Cluster which investigates the molecular mechanisms of disease using human tissue, genetics and artificial intelligence. Kenneth is Professor of Experimental Medicine at the University of Edinburgh, Co-director of the Baillie Gifford Pandemic Science Hub, and a consultant in critical care medicine at the Royal Infirmary, Edinburgh. He contributed to the design and set-up of the clinical trials that discovered the first four effective treatments for severe COVID-19, and discovered a genetic clue that led directly to one of those treatments – the first example of translation from host genetics to drug treatment in an infectious disease.
